SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001203311-20-000079
Filing Date
2020-08-18
Accepted
2020-08-18 19:53:45
Documents
1
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5516
  Complete submission text file 0001203311-20-000079.txt   6941
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Issuer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
LOVE TED W (Reporting) CIK: 0001188919 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 201115018